Protocol for dynamic high-throughput cell death screening of primary phagocytes following microplastic and

Tim Leonardus Philip Skrabanja1, Joëlle Anna Zoetje Klazen1, Sarah Sayed1

  • 1Department of Respiratory Medicine, Center of Translational Immunology, University Medical Center Utrecht, Lundlaan 6, Mail Room KC02.085.2, 3584 EA Utrecht, the Netherlands.

STAR Protocols
|November 15, 2025
PubMed

Insights

Micro- and nanoplastics (MNPs) enter the bloodstream and expose phagocytes. This protocol enables high-throughput screening of phagocyte cell death after MNP exposure, aiding toxicity assessments.

Area of Science:

  • Environmental Science
  • Toxicology
  • Cell Biology

Background:

  • Micro- and nanoplastics (MNPs) pose environmental and health risks.
  • MNPs can penetrate biological barriers, reaching systemic circulation.
  • Phagocytes encounter MNPs but cannot degrade them, raising concerns about cellular toxicity.

Purpose of the Study:

  • To develop a high-throughput protocol for assessing primary phagocyte cell death induced by MNPs.
  • To provide a standardized method for evaluating the cytotoxic effects of MNPs on immune cells.

Main Methods:

  • Isolation of primary phagocytes from biological samples.
  • Co-culture of phagocytes with MNPs under controlled conditions.
  • Time-lapse live-cell imaging using the IncuCyte S3 system for monitoring cell viability.
  • Detailed image analysis procedures for quantifying cell death.

Main Results:

  • The protocol allows for efficient and reproducible screening of MNP-induced phagocyte toxicity.
  • Quantitative data on cell death rates can be obtained rapidly.
  • The method facilitates comparative toxicity assessments of different MNP types and sizes.

Conclusions:

  • This protocol offers a robust platform for investigating the impact of MNPs on phagocyte health.
  • It supports the assessment of MNP-related health risks and informs regulatory strategies.
  • Further research can utilize this method to explore mechanisms of MNP toxicity in immune cells.